UPDATE : Monday, February 17, 2020
JW Pharmaceutical turns to loss on reduced sales of nutrients
JW Pharmaceutical said it reported operating loss in 2019, turning from an ...
by Jeong Sae-im  |  2020-02-14 12:03
Coronavirus kills graduation ceremonies at medical, nursing schools
Weighed by growing fears of the spread of the novel coronavirus (COVID-19),...
by Jeong Sae-im  |  2020-02-12 11:43
‘Worst has passed in new coronavirus outbreak’
The new coronavirus outbreak’s worst situation has passed because the growt...
by Jeong Sae-im  |  2020-02-10 16:08
AstraZeneca Korea leaves umbrella trade union
AstraZeneca Korea’s branch of the Korea Democratic Pharmaceutical Union sai...
by Jeong Sae-im  |  2020-02-07 14:35
Medytox, Daewoong in final battle over BTX strain ownership
The legal dispute between Medytox and Daewoong Pharmaceutical over the sour...
by Jeong Sae-im  |  2020-02-05 12:41
Sillajen's loss more than doubles due to Pexa-Vec trial failure
Sillajen’s losses more than doubled last year as the company failed its pha...
by Jeong Sae-im  |  2020-02-03 16:08
Kolon CEO arrested for mislabeling Invossa’s ingredient
A local court issued an arrest warrant for Kolon Life Science CEO Lee Woo-s...
by Jeong Sae-im  |  2020-02-03 15:34
Drug firms minimize gatherings, hospital visits as coronavirus fear spreads
The local pharmaceutical industry is canceling annual events and meetings a...
by Jeong Sae-im  |  2020-02-03 15:21
Samsung BioLogics’ annual sales up 30% on contract research growth
Samsung BioLogics saw its earnings surge last year, as it pursued more cont...
by Jeong Sae-im  |  2020-01-23 14:47
MIT promotes industrial liaison program to Korean drugmakers
“In Boston, corporations are making successful cases through collaboration ...
by Jeong Sae-im  |  2020-01-23 12:04
Daewoong’s Jeuveau sold ₩40 billion in US in 8 months
Daewoong Pharmaceutical said the U.S. sales of its botulinum toxin Nabota (...
by Jeong Sae-im  |  2020-01-21 11:43
Korea’s botulinum toxin exports hit record high in 2019
Exports of botulinum toxin products recorded the largest volume last year i...
by Jeong Sae-im  |  2020-01-20 11:38
Korea’s biopharma power shines at JP Morgan Healthcare meet
Korean pharmaceutical and biotech companies showed off their technological ...
by Jeong Sae-im  |  2020-01-17 15:20
HLB stocks fall in after-hours trading due to interview on rivoceranib
HLB, a Kosdaq-listed firm, said it would introduce new anticancer pipelines...
by Jeong Sae-im  |  2020-01-16 15:46
[News Focus] Korean firms boast healthcare tech power at CES
LAS VEGAS, Nev. – The world’s largest home appliances and IT exhibiti...
by Jeong Sae-im  |  2020-01-14 11:45
[CES 2020] ‘Smoking disturbs sleep more than coffee does’
LAS VEGAS, Nev. – “The reason sleep deprivation is still not resolved...
by Jeong Sae-im  |  2020-01-09 11:57
[New Year Special] Natural stomach drugs get popular after ranitidine ban
In the wake of the ranitidine recall, other antiulcer “tidine-class” drugs,...
by Jeong Sae-im  |  2020-01-07 16:12
[New Year Special] Boryung, Hanmi in fierce battle to fill ranitidine void
After the regulator kicked ranitidine and nizatidine out of the market due ...
by Jeong Sae-im  |  2020-01-03 17:56
[New Year Special] Biotech rookies may shake up market cap rankings
Korean biotech companies, which drove up the buying spree on the Kosdaq mar...
by Jeong Sae-im  |  2020-01-02 14:31
Korea’s biopharmaceutical technology exports top ₩8 trillion won
This was a good year for Korean biopharmaceutical companies in licensing ou...
by Jeong Sae-im  |  2019-12-30 15:26
Back to Top